Wird geladen...
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
SIMPLE SUMMARY: Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling is associated with an increased risk of thromboembolic and bleeding complications in cancer patients and may cause fatal side effects. The multityrosine kinase inhibitor sorafenib represents an important trea...
Gespeichert in:
| Veröffentlicht in: | Cancers (Basel) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7602103/ https://ncbi.nlm.nih.gov/pubmed/33066190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102961 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|